74
78
Growth Score
-11 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
42928
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.
- Richard Hoffman: Executive Vice President and General CounselPast Role: Goodwin Procter, Partner
- Mohamed Issa: Executive Vice President and Head of U.S OncologyPast Role: Johnson & Johnson Services, Inc., SVP of US Commercial, Immunology, Dermatology, and Rheumatology
About the Company
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with Novartis, Eli Lilly, and Pfizer, Incyte intends to
promote the clinical development and global commercialization of several of their compounds.
